ADA is associated with the toxic accumulation of triphosphorylated deoxyadenosine and lymphocyte depletion, as shown in ADA genetic deficiency and in patients treated with cladribine [98]. The gene discussed is ADA; the disease is hyperinsulinemic hypoglycemia, familial, 4.